Florida, Lorna P.
HRN: 21-30-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2022
CEFUROXIME 1.5GM (VIAL)
04/30/2022
04/30/2022
IVT
1.5gm
IVT Now ANST As LD
UTI; Pus Cells: 10-15
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes